Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Protective effect of Tie2 on retina and vein vessels in other tissues and application of Tie2

A technology of retinal veins and veins, applied in the protective effect and application field of Tie2 on veins and vessels in the retina and other tissues, can solve the problem of ineffective regulation of blood vessels, and achieve the effect of controlling the degree of lesions

Active Publication Date: 2017-08-01
何玉龙
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the common disadvantage of these two models is that they cannot effectively control the degree of vascular abnormalities.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Protective effect of Tie2 on retina and vein vessels in other tissues and application of Tie2
  • Protective effect of Tie2 on retina and vein vessels in other tissues and application of Tie2
  • Protective effect of Tie2 on retina and vein vessels in other tissues and application of Tie2

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] The establishment of embodiment 1 conditional gene knockout mouse model

[0072] Use Tie2 + / - Mice mated with transgenic mice expressing UBC-CreERT2 or VE-Cadherin-Cre / ERT2 to obtain Tie2 + / - ; UBC-Cre / ERT2 or Tie2 flox / - ; VE-Cadherin-Cre / ERT2 mice, and then use this mouse with Tie2 flox / flox Mice mated to Tie2 flox / - ; UBC-Cre / ERT2 or Tie2 flox / - ; VE-Cadherin-Cre / ERT2 (also known as Tie2 in the present invention - / iKO ), mice of this genotype were used as experimental mice, and Tie2 obtained at the same time flox / + ; UBC-Cre / ERT2 or Tie2 flox / + ; VE-Cadherin-Cre / ERT2 was used as a control mouse (Control).

Embodiment 2

[0073] Example 2Tie2 gene knockout and detection of its knockout efficiency

[0074] The experimental mice obtained in Example 1 and the control group were subjected to the following experiments respectively, that is, the Tie2 gene knockout was induced in the following stages:

[0075] (1) From the first day of birth (P1) to the fourth day (P4), each mouse was injected (intragastrically) with 60ug of tamoxifen every day for 4 consecutive days;

[0076] (2) From the 5th day (P5) to the 8th day (P8), each mouse was injected (intragastrically) with 100ug of tamoxifen every day for 5 consecutive days;

[0077]The mouse in Example 1 was induced to knock out the gene after birth, and the lung tissue was analyzed on the 7th day. Extract the lung tissue of the induced transgenic mouse, add the tissue lysate containing protease inhibitors to fully homogenize and lyse, centrifuge, add the supernatant solution, add the sample buffer and boil for 15 minutes, then perform polyacrylamide ...

Embodiment 3

[0079] Example 3 Tie2 Gene Knockout and Detection of Retinal Vein Vascular Lesions in Retinal Tissue

[0080] The mouse in Example 1 was induced to knock out the gene after birth, and the retinal blood vessels were analyzed on the 7th day. Mouse eyeballs were removed and observed by immunofluorescence, Tie2 - / iKO Compared with the littermate control mice, the preretinal vein vessel growth was significantly increased ( figure 2 A), the quantitative results of blood vessel density at the venous end and arterial end are as follows figure 2 As shown, the vascular density of the blood vessels around the venous end increased ( figure 2 B), while the vessel density around the vessels at the retinal artery end did not change ( figure 2 C),. And we also observe that Tie2 - / iKO The mice had abnormal morphology of retinal veins and degeneration of vein characteristics, accompanied by increased angiogenesis around the veins (capillary neogenesis was indicated by the molecular mar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to protective effect of Tie2 on retina and vein vessels in other tissues and application of Tie2, specifically to application of a Tie2 regulating compound in the preparation of a medicine for treating diseases of veins and related vessels in tissues and organs such as retina, skin, liver, lung and the like. The invention also relates to a conditioned tyrosine kinase receptor Tie2 gene knockout non-human animal model closely related with the degree of vein vessel diseases of tissues such as retina and the like and a preparation method thereof, and application of the model in screening of the Tie2 regulating compound. By combining different doses of tamoxifen and different animal growth stages for treatment, the non-human animal models with different Tie2 gene knockout efficiencies are obtained to simulate different degrees of vein vessel diseases of tissues such as retina and the like. According to the invention, the controllability problem of the degree of vein vessel diseases of tissues such as retina and the like is solved.

Description

technical field [0001] Use of the Tie2 regulating compound of the present invention in the preparation of medicines for treating venous and related vascular lesions in tissues and organs such as retina, skin, and liver. The present invention also relates to a non-human transgenic animal model and its construction method and application, in particular to a controllable retinal and other tissue venous vascular disease Tie2 gene knockout induced by different doses of tamoxifen at different growth stages In addition to the transgenic mouse animal model and its construction method. Background technique [0002] Vein-related diseases include venous thrombosis, varicose veins, and venous inflammation. At present, little is known about the pathological process of clinical venous vascular disease, and the treatment options are limited. Therefore, the preparation of related disease models has important scientific value and application significance for elucidating the mechanism of ve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K49/00A61K31/138A61P9/10A61P9/14A01K67/02
CPCA01K67/02A01K67/0276A01K2217/075A01K2217/15A01K2227/105A01K2267/03A61K45/00A61K49/0008A61P1/16A61P9/10A61P9/14A61P11/00A61P17/00A61P27/02A61P29/00
Inventor 何玉龙储蔓李桃桃
Owner 何玉龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com